Literature DB >> 12808126

Establishment and characterization by gene expression profiling of a new diffuse large B-cell lymphoma cell line, EJ-1, carrying t(14;18) and t(8;14) translocations.

Andre Goy1, Latha Ramdas, Yvonne K Remache, Jun Gu, Luis Fayad, Kimberly J Hayes, Kevin R Coombes, Bedia A Barkoh, Ruth Katz, Richard Ford, Fernando Cabanillas, Frederic Gilles.   

Abstract

Entities:  

Mesh:

Year:  2003        PMID: 12808126     DOI: 10.1097/01.lab.0000074890.89650.ad

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


× No keyword cloud information.
  5 in total

Review 1.  Understanding pathogenetic aspects and clinical presentation of primary effusion lymphoma through its derived cell lines.

Authors:  Antonino Carbone; Ethel Cesarman; Annunziata Gloghini; Hans G Drexler
Journal:  AIDS       Date:  2010-02-20       Impact factor: 4.177

2.  Efficient infection of a human B cell line with cell-free Kaposi's sarcoma-associated herpesvirus.

Authors:  Stephen J Dollery; Rey J Santiago-Crespo; Lela Kardava; Susan Moir; Edward A Berger
Journal:  J Virol       Date:  2013-11-20       Impact factor: 5.103

3.  Establishment and characterization of a novel MYC/BCL2 "double-hit" diffuse large B cell lymphoma cell line, RC.

Authors:  Lan V Pham; Gary Lu; Archito T Tamayo; Juan Chen; Pramoda Challagundla; Jeffrey L Jorgensen; L Jeffrey Medeiros; Richard J Ford
Journal:  J Hematol Oncol       Date:  2015-10-29       Impact factor: 17.388

4.  Establishment and characterization of a novel 'double-hit' follicular lymphoma cell line, FL-SJC.

Authors:  Min Chen; Guoxiong Jiang; Yichen Liu; Dongya Li; Tiantian Li; Jie Peng; Qian Jiang; Haiyan You; Rong Ba; Jinlan Pan; Mei Li; Weiguo Long; Jinsong Yan; Yan Zhu; Yun Wang; Xiaodong Xi; Jianhua Mao; Xiaofeng Shi
Journal:  J Cell Mol Med       Date:  2020-05-27       Impact factor: 5.310

5.  Preclinical efficacy and biological effects of the oral proteasome inhibitor ixazomib in diffuse large B-cell lymphoma.

Authors:  Wei Liu; Juan Chen; Archito T Tamayo; Changgeng Ruan; Li Li; Shouhao Zhou; Chan Shen; Ken H Young; Jason Westin; Richard E Davis; Shimin Hu; Leonard J Medeiros; Richard J Ford; Lan V Pham
Journal:  Oncotarget       Date:  2017-08-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.